USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	064792/0500			Pages:	12
		Recorded:	09/01/2023
Conveyance:	ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).

Total properties: 19

Patent #:	11690828	Issue Dt:	07/04/2023	Application #:	16348359	Filing Dt:	05/08/2019
Publication #:	US20190343813	Pub Dt:	11/14/2019
Title:	TREATMENT OF CNS DISEASES WITH sGC STIMULATORS

Patent #:	NONE	Issue Dt:	07/04/2023	Application #:	16348359	Filing Dt:	05/08/2019
Publication #:	US20190343813	Pub Dt:	11/14/2019			PCT #:	US2017060299
Title:	TREATMENT OF CNS DISEASES WITH sGC STIMULATORS

Patent #:	11466014	Issue Dt:	10/11/2022	Application #:	16976249	Filing Dt:	08/27/2020
Publication #:	US20210032254	Pub Dt:	02/04/2021
Title:	PROCESS FOR PREPARING SOLUBLE GUANYLATE CYCLASE STIMULATORS

Patent #:	NONE	Issue Dt:	10/11/2022	Application #:	16976249	Filing Dt:	08/27/2020
Publication #:	US20210032254	Pub Dt:	02/04/2021			PCT #:	US2019021076
Title:	PROCESS FOR PREPARING SOLUBLE GUANYLATE CYCLASE STIMULATORS

Patent #:	11466015	Issue Dt:	10/11/2022	Application #:	16976430	Filing Dt:	08/27/2020
Publication #:	US20210115050	Pub Dt:	04/22/2021
Title:	CRYSTALLINE FORMS OF 8-(2-FLUOROBENZYL)-6-(3-(TRIFLUOROMETHYL)-1H-1,2,4-TRIAZOL-5-YL)IMIDAZO[1,2-a]PYRAZINE AS sGC STIMULATORS

Patent #:	NONE	Issue Dt:	10/11/2022	Application #:	16976430	Filing Dt:	08/27/2020
Publication #:	US20210115050	Pub Dt:	04/22/2021			PCT #:	US2019021080
Title:	CRYSTALLINE FORMS OF 8-(2-FLUOROBENZYL)-6-(3-(TRIFLUOROMETHYL)-1H-1,2,4-TRIAZOL-5-YL)IMIDAZO[1,2-a]PYRAZINE AS sGC STIMULATORS

Patent #:	NONE	Issue Dt:		Application #:	17258913	Filing Dt:	01/08/2021
Publication #:	US20210177846	Pub Dt:	06/17/2021
Title:	USE OF sGC STIMULATORS FOR THE TREATMENT OF MITOCHONDRIAL DISORDERS

Patent #:	NONE	Issue Dt:		Application #:	17258913	Filing Dt:	01/08/2021
Publication #:	US20210177846	Pub Dt:	06/17/2021			PCT #:	US2019041437
Title:	USE OF sGC STIMULATORS FOR THE TREATMENT OF MITOCHONDRIAL DISORDERS

Patent #:	NONE	Issue Dt:		Application #:	17954713	Filing Dt:	09/28/2022
Publication #:	US20230095799	Pub Dt:	03/30/2023
Title:	CRYSTALLINE FORMS OF AN sGC STIMULATOR

Patent #:	NONE	Issue Dt:		Application #:	17954725	Filing Dt:	09/28/2022
Publication #:	US20230128639	Pub Dt:	04/27/2023
Title:	SUBSTITUTED AMIDRAZONES AS INTERMEDIATES IN THE PROCESS FOR PREPARING SOLUBLE GUANYLATE CYCLASE STIMULATORS

Patent #:	NONE	Issue Dt:		Application #:	18031371	Filing Dt:	04/12/2023
Publication #:	US20230372335	Pub Dt:	11/23/2023
Title:	TREATMENT OF COGNITIVE IMPAIRMENT WITH A CNS-PENETRANT sGC STIMULATOR

Patent #:	NONE	Issue Dt:		Application #:	18031371	Filing Dt:	04/12/2023
Publication #:	US20230372335	Pub Dt:	11/23/2023			PCT #:	US2021054632
Title:	TREATMENT OF COGNITIVE IMPAIRMENT WITH A CNS-PENETRANT sGC STIMULATOR

Patent #:	NONE	Issue Dt:		Application #:	18196826	Filing Dt:	05/12/2023
Publication #:	US20230381153	Pub Dt:	11/30/2023
Title:	TREATMENT OF CNS DISEASES WITH sGC STIMULATORS

Assignor

Exec Dt:

07/27/2023

Assignee

245 FIRST STREET, RIVERVIEW II, 18TH FLOOR

CAMBRIDGE, MASSACHUSETTS 02142

Correspondence name and address
	XIN ZHANG
	265 FRANKLIN STREET
	MCCARTER ENGLISH LLP
	BOSTON, MA 02110

Search Results as of: 05/31/2024 07:28 AM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6